Daphné Morel

1.5k total citations · 1 hit paper
20 papers, 636 citations indexed

About

Daphné Morel is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daphné Morel has authored 20 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daphné Morel's work include Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (4 papers) and Chromatin Remodeling and Cancer (4 papers). Daphné Morel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (4 papers) and Chromatin Remodeling and Cancer (4 papers). Daphné Morel collaborates with scholars based in France, United States and United Kingdom. Daphné Morel's co-authors include Sophie Postel‐Vinay, Sandrine Aspeslagh, Geneviève Almouzni, Daniel Jeffery, Jean‐Charles Soria, Loïc Verlingue, François‐Xavier Danlos, Daniel Gautheret, Aurélien Marabelle and Andreï Zinovyev and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Daphné Morel

19 papers receiving 627 citations

Hit Papers

Combining epigenetic drugs with other therapies for solid... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
    2019 313 citations Daphné Morel, Daniel Jeffery et al. Nature Reviews Clinical Oncology profile →

Peers

Daphné Morel
Steve Guerrero United States
Qian Zhu China
Khalil Choucair United States
Joe Yeong Singapore
Xihu Yang China
Mariëlle Herzog Belgium
Koshi Akahane Japan
Marta Nekulová Czechia
Charles Ming Lok Chan Hong Kong
Virginia Picasso Italy
Steve Guerrero United States
Daphné Morel
Citations per year, relative to Daphné Morel Daphné Morel (= 1×) peers Steve Guerrero

Countries citing papers authored by Daphné Morel

Since Specialization
Citations

This map shows the geographic impact of Daphné Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphné Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphné Morel more than expected).

Fields of papers citing papers by Daphné Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphné Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphné Morel. The network helps show where Daphné Morel may publish in the future.

Co-authorship network of co-authors of Daphné Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Daphné Morel. A scholar is included among the top collaborators of Daphné Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphné Morel. Daphné Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morel, Daphné, et al.. (2025). Radiation-Induced Lymphopenia: From Mathematical Modeling Toward Mechanistic Learning. International Journal of Radiation Oncology*Biology*Physics. 124(2). 465–483. 1 indexed citations
2.
Laurent, Pierre-Antoine, Shi Liu, Daphné Morel, et al.. (2025). Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect. Journal for ImmunoTherapy of Cancer. 13(6). e011487–e011487. 2 indexed citations
3.
Verlingue, Loïc, et al.. (2024). Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice. The Lancet Regional Health - Europe. 46. 101064–101064. 16 indexed citations
4.
Limkin, Elaine Johanna, Ibrahima Diallo, Daphné Morel, et al.. (2024). LymphoDose: a lymphocyte dose estimation framework—application to brain radiotherapy. Physics in Medicine and Biology. 69(10). 105009–105009. 6 indexed citations
5.
Delaye, Matthieu, Arthur Géraud, Angélo Paci, et al.. (2024). Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review. Journal of Pain and Symptom Management. 67(6). e859–e868.
6.
Borisova, Тatiana, François Lux, Halyna Kuznietsova, et al.. (2024). Enhancing radioprotection: A chitosan-based chelating polymer is a versatile radioprotective agent for prophylactic and therapeutic interventions against radionuclide contamination. PLoS ONE. 19(4). e0292414–e0292414. 4 indexed citations
7.
Morel, Daphné, Charlotte Robert, Nikos Paragios, Vincent Grégoire, & Éric Deutsch. (2024). Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy. Clinical Cancer Research. 30(11). 2317–2332. 8 indexed citations
8.
Laurent, Pierre-Antoine, Lydia Meziani, Daphné Morel, et al.. (2023). KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner. Journal of Translational Medicine. 21(1). 773–773. 5 indexed citations
9.
Meziani, Lydia, Michele Mondini, Céline Clémenson, et al.. (2023). Radio-induced lymphopenia in the era of anti-cancer immunotherapy. International review of cell and molecular biology. 378. 1–30. 21 indexed citations
10.
Martín-Romano, Patricia, Léo Colmet‐Daage, Daphné Morel, et al.. (2022). Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials. European Journal of Cancer. 173. 133–145. 1 indexed citations
11.
Espenel, Sophie, Cyrus Chargari, Pierre Blanchard, et al.. (2022). Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials. European Journal of Cancer. 171. 242–258. 6 indexed citations
12.
Laurent, Pierre-Antoine, Daphné Morel, Lydia Meziani, Stéphane Depil, & Éric Deutsch. (2022). Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors. OncoImmunology. 12(1). 2158013–2158013. 17 indexed citations
13.
Morel, Daphné, François‐Xavier Danlos, Aurélien Marabelle, et al.. (2021). Applications of single-cell and bulk RNA sequencing in onco-immunology. European Journal of Cancer. 149. 193–210. 81 indexed citations
14.
Chabanon, Roman M., Daphné Morel, Léo Colmet‐Daage, et al.. (2020). Abstract 1058: Targeting chromatin remodeling-associated genetic vulnerabilities in cancer: PBRM1 defects are synthetic lethal with PARP and ATR inhibitors. Cancer Research. 80(16_Supplement). 1058–1058. 2 indexed citations
15.
Morel, Daphné, Daniel Jeffery, Sandrine Aspeslagh, Geneviève Almouzni, & Sophie Postel‐Vinay. (2019). Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise. Nature Reviews Clinical Oncology. 17(2). 91–107. 313 indexed citations breakdown →
16.
Chabanon, Roman M., Daphné Morel, & Sophie Postel‐Vinay. (2019). Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers. Seminars in Cancer Biology. 61. 180–198. 25 indexed citations
17.
Aspeslagh, Sandrine, Daphné Morel, Jean‐Charles Soria, & Sophie Postel‐Vinay. (2018). Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Annals of Oncology. 29(4). 812–824. 64 indexed citations
18.
Hartl, Dana M., Daphné Morel, Christophe Massard, et al.. (2017). Otorhinolaryngological Toxicities of New Drugs in Oncology. Advances in Therapy. 34(4). 866–894. 1 indexed citations
19.
Morel, Daphné, Geneviève Almouzni, Jean‐Charles Soria, & Sophie Postel‐Vinay. (2016). Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism. Annals of Oncology. 28(2). 254–269. 62 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Guerrero Breakdown of academic impact, for papers by Qian Zhu Breakdown of academic impact, for papers by Khalil Choucair Breakdown of academic impact, for papers by Joe Yeong Breakdown of academic impact, for papers by Xihu Yang Breakdown of academic impact, for papers by Mariëlle Herzog Breakdown of academic impact, for papers by Koshi Akahane Breakdown of academic impact, for papers by Marta Nekulová Breakdown of academic impact, for papers by Charles Ming Lok Chan Breakdown of academic impact, for papers by Virginia Picasso
Rankless by CCL
2026